METROPOLITAN LIFE INSURANCE CO/NY - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 86 filers reported holding SPERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$111,862
-13.0%
6,9870.0%0.00%0.0%
Q3 2021$128,631
+31.9%
6,9870.0%0.00%
+100.0%
Q2 2021$97,539
+27.8%
6,987
+34.8%
0.00%0.0%
Q1 2021$76,323
-40.3%
5,185
-21.3%
0.00%
-50.0%
Q4 2020$127,780
+80.7%
6,590
+26.1%
0.00%
+100.0%
Q2 2020$70,7215,2270.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,376,968$15,849,00016.95%
Aquilo Capital Management, LLC 1,154,356$13,287,0004.61%
VHCP Management II, LLC 474,015$5,456,0001.72%
AWM Investment Company, Inc. 598,315$6,887,0001.32%
BVF INC/IL 939,704$10,816,0001.18%
Novo Holdings A/S 465,983$5,363,0000.75%
DAFNA Capital Management LLC 70,000$806,0000.30%
Artal Group S.A. 540,000$6,215,0000.25%
Alphabet Inc. 1,112,473$12,805,0000.24%
Rock Springs Capital Management LP 525,000$6,043,0000.22%
View complete list of SPERO THERAPEUTICS INC shareholders